Bio-Works Technologies
Bio-Works receives WorkBeads order worth SEK 2.5 million
REG
The customer is a global contract development and manufacturing organization (CDMO) focused on peptide- and oligonucleotide-based therapies.
“The order from a returning global CDMO confirms our strong position in the purification of peptide- and oligonucleotide-based pharmaceuticals. It is a clear sign that Bio-Works delivers solutions that meet the highest standards of quality and performance,” says Lone Carlbom, CEO of Bio-Works.
This disclosure contains information that Bio-Works Technologies AB is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on 15-05-2025 15:02 CET.
| Datum | 2025-05-15, kl 15:02 |
| Källa | Cision |
Hej Serverägare! Har du problem med troll och spam? Nu finns möjligheten att sätta en liten avgift, t.ex. 20kr, på discord invites och därmed stoppa många återkommande troll samtidigt som du tjänar lite pengar. Kolla in Invite Paywall.